These novel findings provide a structural basis for future TRPV1-dependent and TRPV1-independent studies on the primary afferent innervation of PrAT, which may be of interest for the development of future therapeutic obesity and CVD interventions. This evidence concerns the gene TRPV1 and obesity due to melanocortin 4 receptor deficiency.